Zhejiang Medicine Co., Ltd. (SHA:600216)

Market Cap	13.41B +8.5%
Revenue (ttm)	8.82B -6.0%
Net Income	751.31M -48.5%
EPS	0.78 -49.3%
Shares Out	947.91M
PE Ratio	18.12
Forward PE	11.98
Dividend	0.37 (2.65%)
Ex-Dividend Date	Jul 21, 2025

Volume	3,131,278
Average Volume	18,366,028
Open	14.08
Previous Close	14.15
Day's Range	13.85 - 14.08
52-Week Range	13.48 - 18.58
Beta	0.58
RSI	38.76
Earnings Date	Aug 25, 2026

About Zhejiang Medicine

Zhejiang Medicine Co., Ltd. produces and sells life nutrition and pharmaceutical products in China. The company offers life nutrition products, such as synthetic vitamin E, vitamin A, natural vitamin E, vitamin H, vitamin D3, coenzyme Q10, carotene, cantharidin, lutein, lycopene, and other vitamins and vitamin products. It also provides pharmaceutical manufacturing products, including anti-drug resistant antibiotics, anti-malaria and other pharmaceutical raw materials, quinolones, and anti-drug resistant products; and pharmaceutical products co...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 5,417
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600216

Financial Performance

In 2025, Zhejiang Medicine's revenue was 8.88 billion, a decrease of -5.28% compared to the previous year's 9.38 billion. Earnings were 873.38 million, a decrease of -24.74%.